Хуудас 1 -аас 43 үр дүн
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a process for preparing a radioactive arsenic-containing compound and uses of the radioactive arsenic-containing compound in the treatment of tumors/cancers such as hematological malignancies and solid tumors.
FIELD OF INVENTION
This invention relates to methods of inhibiting cancer by affecting expression, translation, and biological activity of cancers overexpressing or dependent on cyclin D1 using arsenic trioxide.
BACKGROUND OF THE INVENTION
Mantle cell lymphoma (MCL) is a well-defined subtype of B
1. FIELD OF INVENTION
The present invention relates to methods and compositions for the treatment of primary and metastatic neoplastic diseases, including, but not limited to human sarcomas, carcinomas and hematopoietic disorders. In the practice of the treatment of cancer, compositions containing
1. FIELD OF INVENTION
The present invention relates to methods and compositions for the treatment of primary and metastatic neoplastic diseases, including, but not limited to human sarcomas, carcinomas and hematopoietic disorders. In the practice of the treatment of cancer, compositions containing
1. FIELD OF INVENTION
The present invention relates to methods and compositions for the treatment of primary and metastatic neoplastic diseases, including, but not limited to human sarcomas, carcinomas and hematopoietic disorders. In the practice of the treatment of cancer, compositions containing
FIELD OF INVENTION
The present invention relates to methods and compositions for the treatment of primary and metastatic neoplastic diseases, including, but not limited to human sarcomas, carcinomas and hematopoietic disorders. In the practice of the treatment of cancer, compositions containing
FIELD OF THE INVENTION
The present invention relates to the identification of HD-2, a natural chemical substance that was separated and purified from a natural product, Sinsuk, as arsenic hexoxide (As.sub.4 O.sub.6) and about its therapeutic efficacy as an anti-cancer drug and pharmaceutical
FIELD OF THE INVENTION
The present invention relates to the identification of HD-2, a natural chemical substance that was separated and purified from a natural product, Sinsuk, as arsenic hexoxide (As.sub.4 O.sub.6) and about its therapeutic efficacy as an anti-cancer drug and pharmaceutical
1. FIELD OF INVENTION
The present invention relates to methods and compositions for the treatment of leukemia, lymphoma, and certain other cancers.
More specifically, the present invention relates to the novel uses of arsenic trioxide and an organic arsenic compound for treating acute leukemia and
FIELD OF INVENTION
The present invention relates to methods and compositions for the treatment of leukemia, lymphoma, and certain other cancers.
More specifically, the present invention relates to the novel uses of arsenic trioxide and an organic arsenic compound for treating acute leukemia and
1. FIELD OF INVENTION
The present invention relates to methods and compositions for the treatment of leukemia, lymphoma, and certain other cancers.
More specifically, the present invention relates to the novel uses of arsenic trioxide and an organic arsenic compound for treating acute leukemia and
1. FIELD OF INVENTION
The present invention relates to methods and compositions for the treatment of leukemia, lymphoma, and certain other cancers.
More specifically, the present invention relates to the novel uses of arsenic trioxide and an organic arsenic compound for treating acute leukemia and
1. FIELD OF INVENTION
The present invention relates to methods and compositions for the treatment of leukemia, lymphoma and certain other cancers.
More specifically, the present invention relates to the novel uses of arsenic trioxide and an organic arsenic compound for treating acute leukemia and
1. FIELD OF INVENTION
The present invention relates to methods and compositions for the treatment of leukemia, lymphoma, and certain other cancers.
More specifically, the present invention relates to the novel uses of arsenic trioxide and an organic arsenic compound for treating acute leukemia and
1. FIELD OF INVENTION
The present invention relates to methods and compositions for the treatment of leukemia, lymphoma, and certain other cancers.
More specifically, the present invention relates to the novel uses of arsenic trioxide and an organic arsenic compound for treating acute leukemia and